PAUL SUTEJ, MD

Administration of chemotherapy into vein, 1 hour or less

New patient office or other outpatient visit, 45-59 minutes

Established patient office or other outpatient visit, 30-39 minutes

Aspiration and/or injection of fluid from large joint

Established patient office or other outpatient visit, 20-29 minutes

Injection, rituximab, 10 mg

Administration of chemotherapy into vein, each additional hour

Tuberculosis test, gamma interferon

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Injection, infliximab, excludes biosimilar, 10 mg

Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Aspiration and/or injection of fluid from small joint

Injection, golimumab, 1 mg, for intravenous use

Measurement of antibody for rheumatoid arthritis assessment

Injection of additional new drug or substance into vein

Injection, denosumab, 1 mg

Blood test, comprehensive group of blood chemicals

Analysis of substance using immunoassay technique, multiple step method

Injection, zoledronic acid, 1 mg

Injection of drug or substance under skin or into muscle

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Rheumatoid factor level

Injection, methylprednisolone sodium succinate, up to 125 mg

Injection, methylprednisolone acetate, 40 mg

Measurement c-reactive protein for detection of infection or inflammation

Uric acid level, blood

Injection, tocilizumab, 1 mg

Red blood cell sedimentation rate, to detect inflammation, automated

Injection, methylprednisolone acetate, 20 mg